GPC3 and hepatocellular carcinoma: These findings demonstrate that ET58-DOTA-Gd selectively accumulates and is retained in orthotopic GPC3-positive HCC cells, supporting its potential utility for high-sensitivity molecular MRI applications in identifying this subgroup of patients.